One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy-and an aggressive type ...

Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease ...

One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy—and an aggressive type ...

If there are no dose-limiting toxicities, the company will test the CAR T-cell therapy at higher doses in more patients with FLT3-expressing refractory AML.

Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients ...

Outcomes of older patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remain unsatisfactory. The primary objective of this trial was to ...

A Manitoba health authority has admitted an Indigenous man, who died four months after a delayed confirmation his cancer had ...

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its ...

Magrolimab triple therapy falls short of expectations in a study of previously untreated acute myeloid leukemia.

Here’s a quick look back at Hulk Hogan’s career and impact, where he lived in Florida and what we know about the cause of his death.

Encouraging early results from a SAHMRI-led clinical trial offer new hope to people diagnosed with chronic myelomonocytic leukemia (CMML), a rare and aggressive form of blood cancer.